Back to results
US 11,633,372 B2Granted
Compositions and methods for treating autism
AssigneeYamo Pharmaceuticals LLC
InventorsSteven Hoffman, John Rothman
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods of treating autism. Specifically, the invention relates to treating the core symptoms of autism by administering α-methyl-DL-tyrosine.
Claims18
A method for treating an autism-associated clinical trait in a human in need thereof, comprising:
- administering a daily amount of 100 mg to 750 mg of α-methyl-DL-tyrosine to the human,
- wherein the administration results in a plasma concentration of α-methyl-DL-tyrosine of from about 800 ng/ml to 2500 ng/ml;
- in combination with another treatment method effective in treating autism or an autism-associated clinical trait.
Dependencies are inferred from the claim text.